| 1,2,4-trimethylbenzene | increases expression | ISO | RGD:70069 | 6480464 | pseudocumene results in increased expression of CXCL2 protein | CTD | PMID:17337753 |
| 1,7-dimethylxanthine | multiple interactions | ISO | RGD:733118 | 6480464 | 1,7-dimethylxanthine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL2 mRNA] | CTD | PMID:19962977 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:733118 | 6480464 | Dinitrochlorobenzene results in increased expression of CXCL2 protein | CTD | PMID:16675337 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CXCL2 mRNA | CTD | PMID:20146380 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:733118 | 6480464 | Dinitrochlorobenzene results in increased expression of CXCL2 mRNA | CTD | PMID:19647056 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:733118 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CXCL2 protein | CTD | PMID:15130876 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:733118 | 6480464 | [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CXCL2 mRNA | CTD | PMID:21356363 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:733118 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CXCL2 protein | CTD | PMID:15130876 more ... |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:733118 | 6480464 | [Progesterone co-treated with 1-Naphthylisothiocyanate] results in increased expression of CXCL2 mRNA | CTD | PMID:22157104 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:733118 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA | CTD | PMID:20594950 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:70069 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA | CTD | PMID:18364083 PMID:18590720 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:70069 | 6480464 | Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:18590720 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:70069 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA | CTD | PMID:18590720 PMID:18364083 |
| 17-HDoHE | multiple interactions | ISO | RGD:733118 | 6480464 | 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 protein] | CTD | PMID:21724996 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:733118 | 6480464 | Ethinyl Estradiol affects the expression of CXCL2 mRNA | CTD | PMID:15885639 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:733118 | 6480464 | Ethinyl Estradiol promotes the reaction [IL1B protein results in increased expression of CXCL2 mRNA] | CTD | PMID:12072388 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CXCL2 mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of CXCL2 mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | multiple interactions | ISO | RGD:733118 | 6480464 | fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]] | CTD | PMID:21501669 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:70069 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL2 mRNA | CTD | PMID:15644576 PMID:21724226 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733118 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CXCL2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:70069 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CXCL2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CXCL2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733118 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL2 mRNA | CTD | PMID:19770486 PMID:16114106 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733118 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CXCL2 promoter] | CTD | PMID:19654925 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733118 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL2 mRNA | CTD | PMID:16114106 PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:70069 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL2 mRNA | CTD | PMID:15644576 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733118 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL2 mRNA | CTD | PMID:16114106 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:733118 | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CXCL2 mRNA] | CTD | PMID:18200517 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:733118 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of CXCL2 mRNA | CTD | PMID:18200517 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:733118 | 6480464 | [Galactosamine co-treated with Endotoxins] results in increased expression of CXCL2 mRNA; more ... | CTD | PMID:15576625 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:70069 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:70069 | 6480464 | Glucosamine results in increased expression of CXCL2 mRNA | CTD | PMID:17109745 |
| 2-butoxyethanol | increases expression | ISO | RGD:733118 | 6480464 | n-butoxyethanol results in increased expression of CXCL2 mRNA | CTD | PMID:19812364 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:733118 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of CXCL2 mRNA | CTD | PMID:18648102 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:733118 | 6480464 | Oxazolone results in increased expression of CXCL2 mRNA | CTD | PMID:19647056 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:733118 | 6480464 | Fenretinide results in increased expression of CXCL2 mRNA | CTD | PMID:16467112 |
| 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of CXCL2 mRNA | CTD | PMID:15958647 |
| 4-nitroquinoline N-oxide | increases expression | ISO | RGD:733118 | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of CXCL2 mRNA | CTD | PMID:22561872 |
| acrolein | increases expression | ISO | RGD:733118 | 6480464 | Acrolein results in increased expression of CXCL2 mRNA | CTD | PMID:18515264 |
| aflatoxin B1 | increases expression | ISO | RGD:733118 | 6480464 | Aflatoxin B1 results in increased expression of CXCL2 mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:70069 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:70069 | 6480464 | Glucosamine results in increased expression of CXCL2 mRNA | CTD | PMID:17109745 |
| amiloride | multiple interactions | ISO | RGD:733118 | 6480464 | Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL2 protein] | CTD | PMID:11420121 |
| ammonium chloride | affects expression | ISO | RGD:70069 | 6480464 | Ammonium Chloride affects the expression of CXCL2 mRNA | CTD | PMID:16483693 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of CXCL2 mRNA | CTD | PMID:16835338 |
| arsenic atom | decreases expression | ISO | RGD:733118 | 6480464 | Arsenic results in decreased expression of CXCL2 mRNA | CTD | PMID:19654921 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of CXCL2 mRNA | CTD | PMID:12928151 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of CXCL2 mRNA | CTD | PMID:18296743 |
| arsenite(3-) | decreases expression | ISO | RGD:733118 | 6480464 | arsenite results in decreased expression of CXCL2 mRNA | CTD | PMID:18191166 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | Dietary Fats promotes the reaction [arsenite results in increased expression of CXCL2 mRNA] | CTD | PMID:18296743 |
| asbestos | increases expression | ISO | RGD:733118 | 6480464 | Asbestos results in increased expression of CXCL2 protein | CTD | PMID:18795166 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CXCL2 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | affects expression | ISO | RGD:733118 | 6480464 | Benzo(a)pyrene affects the expression of CXCL2 mRNA | CTD | PMID:22342234 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CXCL2 mRNA | CTD | PMID:22316170 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733118 | 6480464 | Benzo(a)pyrene results in decreased expression of CXCL2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:733118 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of CXCL2 mRNA | CTD | PMID:21715664 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:70069 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:17109745 |
| beta-D-glucosamine | increases expression | ISO | RGD:70069 | 6480464 | Glucosamine results in increased expression of CXCL2 mRNA | CTD | PMID:17109745 |
| bilirubin | increases expression | EXP | | 6480464 | Bilirubin results in increased expression of CXCL2 mRNA | CTD | PMID:20196124 |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:733118 | 6480464 | Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:16377760 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:733118 | 6480464 | Mustard Gas results in increased expression of CXCL2 mRNA | CTD | PMID:18200059 more ... |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:733118 | 6480464 | Mustard Gas results in increased expression of CXCL2 mRNA | CTD | PMID:16377760 more ... |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:733118 | 6480464 | Mustard Gas results in increased expression of CXCL2 mRNA | CTD | PMID:18200059 more ... |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:733118 | 6480464 | Mustard Gas results in increased expression of CXCL2 mRNA | CTD | PMID:15674843 more ... |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:733118 | 6480464 | Mustard Gas results in increased expression of CXCL2 mRNA | CTD | PMID:18955075 more ... |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:733118 | 6480464 | RELA protein affects the reaction [Mustard Gas results in increased expression of CXCL2 mRNA] | CTD | PMID:18200059 |
| bis(2-chloroethyl) sulfide | multiple interactions | EXP | | 6480464 | TNF protein affects the reaction [Mustard Gas affects the expression of CXCL2 mRNA] | CTD | PMID:16173061 |
| bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of CXCL2 protein | CTD | PMID:18684396 |
| bleomycin A2 | increases secretion | ISO | RGD:733118 | 6480464 | Bleomycin results in increased secretion of CXCL2 protein | CTD | PMID:22687607 |
| bleomycin A2 | increases expression | ISO | RGD:733118 | 6480464 | Bleomycin results in increased expression of CXCL2 mRNA | CTD | PMID:22687607 |
| budesonide | multiple interactions | ISO | RGD:70069 | 6480464 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:15734790 |
| C60 fullerene | increases expression | ISO | RGD:70069 | 6480464 | fullerene C60 results in increased expression of CXCL2 mRNA | CTD | PMID:20471445 |
| cadmium atom | multiple interactions | ISO | RGD:733118 | 6480464 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Cadmium results in increased expression of CXCL2 mRNA] | CTD | PMID:15010501 |
| cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of CXCL2 mRNA | CTD | PMID:20105457 |
| cadmium atom | increases secretion | ISO | RGD:70069 | 6480464 | Cadmium results in increased secretion of CXCL2 protein | CTD | PMID:20105457 |
| cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of CXCL2 mRNA | CTD | PMID:16439709 |
| cadmium atom | increases expression | ISO | RGD:733118 | 6480464 | Cadmium results in increased expression of CXCL2 mRNA | CTD | PMID:15010501 |
| cadmium dichloride | increases expression | ISO | RGD:733118 | 6480464 | Cadmium Chloride results in increased expression of CXCL2 protein | CTD | PMID:9707512 |
| cadmium dichloride | increases expression | ISO | RGD:733118 | 6480464 | Cadmium Chloride results in increased expression of CXCL2 mRNA | CTD | PMID:16413704 |
| cadmium dichloride | increases methylation | ISO | RGD:70069 | 6480464 | Cadmium Chloride results in increased methylation of CXCL2 promoter | CTD | PMID:22457795 |
| cadmium dichloride | increases expression | ISO | RGD:70069 | 6480464 | Cadmium Chloride results in increased expression of CXCL2 mRNA | CTD | PMID:19010381 |
| cadmium sulfate | increases expression | ISO | RGD:733118 | 6480464 | cadmium sulfate results in increased expression of CXCL2 protein; more ... | CTD | PMID:22094458 |
| capsaicin | increases expression | ISO | RGD:70069 | 6480464 | Capsaicin results in increased expression of CXCL2 protein | CTD | PMID:22150557 |
| capsaicin | multiple interactions | ISO | RGD:70069 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]; more ... | CTD | PMID:22150557 |
| carbamazepine | multiple interactions | ISO | RGD:733118 | 6480464 | Alprostadil inhibits the reaction [Carbamazepine results in increased expression of CXCL2 mRNA] | CTD | PMID:22790970 |
| carbamazepine | increases expression | ISO | RGD:733118 | 6480464 | Carbamazepine results in increased expression of CXCL2 mRNA | CTD | PMID:22790970 |
| carmustine | affects response to substance | EXP | | 6480464 | CXCL2 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| carrageenan | increases expression | ISO | RGD:733118 | 6480464 | Carrageenan results in increased expression of CXCL2 protein | CTD | PMID:12444156 |
| carrageenan | multiple interactions | ISO | RGD:70069 | 6480464 | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CXCL2 protein] | CTD | PMID:14654164 |
| chenodeoxycholic acid | multiple interactions | ISO | RGD:733118 | 6480464 | EGR1 protein promotes the reaction [Chenodeoxycholic Acid results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:21224055 |
| chenodeoxycholic acid | increases expression | ISO | RGD:733118 | 6480464 | Chenodeoxycholic Acid results in increased expression of CXCL2 mRNA; more ... | CTD | PMID:21224055 |
| choline | multiple interactions | ISO | RGD:733118 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with RXRA gene mutant form] results in increased expression of CXCL2 mRNA | CTD | PMID:18952117 |
| choline | multiple interactions | ISO | RGD:733118 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of CXCL2 mRNA | CTD | PMID:20697377 |
| ciprofloxacin | decreases expression | ISO | RGD:733118 | 6480464 | Ciprofloxacin results in decreased expression of CXCL2 protein | CTD | PMID:18197910 |
| cis-caffeic acid | multiple interactions | EXP | | 6480464 | caffeic acid promotes the reaction [Thapsigargin results in decreased expression of CXCL2 mRNA] | CTD | PMID:19442820 |
| cisplatin | multiple interactions | EXP | | 6480464 | CXCL2 protein promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:21271225 |
| cisplatin | increases expression | ISO | RGD:733118 | 6480464 | Cisplatin results in increased expression of CXCL2 mRNA | CTD | PMID:20702592 PMID:15814532 |
| cisplatin | multiple interactions | ISO | RGD:733118 | 6480464 | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CXCL2 mRNA] | CTD | PMID:15814532 |
| cisplatin | increases expression | ISO | RGD:733118 | 6480464 | Cisplatin results in increased expression of CXCL2 protein | CTD | PMID:20844023 |
| cisplatin | increases expression | ISO | RGD:733118 | 6480464 | Cisplatin results in increased expression of CXCL2 mRNA | CTD | PMID:15814532 PMID:20702592 |
| cisplatin | affects expression | ISO | RGD:733118 | 6480464 | Cisplatin affects the expression of CXCL2 mRNA | CTD | PMID:21151649 |
| cisplatin | increases response to substance | EXP | | 6480464 | CXCL2 protein results in increased susceptibility to Cisplatin | CTD | PMID:21271225 |
| cobalt atom | multiple interactions | ISO | RGD:70069 | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CXCL2 protein | CTD | PMID:22198552 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CXCL2 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CXCL2 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:70069 | 6480464 | Copper Sulfate results in increased expression of CXCL2 mRNA | CTD | PMID:11708899 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of CXCL2 mRNA | CTD | PMID:19549813 |
| crocidolite asbestos | multiple interactions | ISO | RGD:70069 | 6480464 | [Asbestos, Crocidolite results in increased abundance of Hydrogen Peroxide] which results in increased expression of CXCL2 mRNA | CTD | PMID:11764986 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of CXCL2 mRNA | CTD | PMID:18687144 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CXCL2 protein; more ... | CTD | PMID:17999991 |
| curcumin | multiple interactions | ISO | RGD:70069 | 6480464 | Curcumin inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased secretion of CXCL2 protein] | CTD | PMID:18001810 |
| curcumin | multiple interactions | ISO | RGD:733118 | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CXCL2 mRNA] | CTD | PMID:18200517 |
| curcumin | multiple interactions | EXP | | 6480464 | NFKBIA protein affects the reaction [Curcumin results in decreased expression of CXCL2 mRNA] | CTD | PMID:17999991 |
| D-glucose | increases expression | ISO | RGD:733118 | 6480464 | Glucose results in increased expression of CXCL2 mRNA | CTD | PMID:17178593 |
| deoxycholic acid | multiple interactions | ISO | RGD:733118 | 6480464 | EGR1 protein promotes the reaction [Deoxycholic Acid results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:21224055 |
| deoxycholic acid | increases expression | ISO | RGD:733118 | 6480464 | Deoxycholic Acid results in increased expression of CXCL2 protein; more ... | CTD | PMID:21224055 |
| desferrioxamine B | multiple interactions | ISO | RGD:70069 | 6480464 | Deferoxamine promotes the reaction [Asbestos, Amphibole results in increased expression of CXCL2] | CTD | PMID:21605006 |
| dexamethasone | multiple interactions | ISO | RGD:733118 | 6480464 | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein] | CTD | PMID:22154906 |
| dexamethasone | multiple interactions | ISO | RGD:70069 | 6480464 | Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA] | CTD | PMID:18590720 |
| dexamethasone | multiple interactions | ISO | RGD:733118 | 6480464 | Dexamethasone inhibits the reaction [Ozone results in increased expression of CXCL2 protein] | CTD | PMID:14754758 |
| dexamethasone | multiple interactions | ISO | RGD:70069 | 6480464 | Dexamethasone inhibits the reaction [Ozone results in increased expression of CXCL2 mRNA] | CTD | PMID:7737418 |
| dextran sulfate | multiple interactions | ISO | RGD:733118 | 6480464 | 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 protein]; more ... | CTD | PMID:21724996 |
| dextran sulfate | increases expression | ISO | RGD:733118 | 6480464 | Dextran Sulfate results in increased expression of CXCL2 protein | CTD | PMID:21724996 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of CXCL2 mRNA] | CTD | PMID:19350554 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CXCL2 mRNA | CTD | PMID:19350554 PMID:19128835 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CXCL2 mRNA | CTD | PMID:19128835 PMID:19350554 |
| diclofenac | increases expression | ISO | RGD:733118 | 6480464 | Diclofenac results in increased expression of CXCL2 mRNA | CTD | PMID:22285467 |
| dicloxacillin | multiple interactions | ISO | RGD:733118 | 6480464 | [Progesterone co-treated with Dicloxacillin] results in increased expression of CXCL2 mRNA | CTD | PMID:22157104 |
| diflorasone diacetate | multiple interactions | ISO | RGD:733118 | 6480464 | diflorasone diacetate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein] | CTD | PMID:12956900 |
| dimercaprol | multiple interactions | ISO | RGD:733118 | 6480464 | Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of CXCL2 mRNA] | CTD | PMID:16377760 |
| dioxygen | increases expression | ISO | RGD:733118 | 6480464 | Oxygen results in increased expression of CXCL2 protein | CTD | PMID:11498801 |
| dioxygen | multiple interactions | ISO | RGD:733118 | 6480464 | POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:22363622 |
| dioxygen | increases expression | ISO | RGD:733118 | 6480464 | Oxygen results in increased expression of CXCL2 mRNA | CTD | PMID:10027076 more ... |
| dioxygen | increases expression | ISO | RGD:733118 | 6480464 | Oxygen results in increased expression of CXCL2 mRNA | CTD | PMID:10027076 PMID:10781441 |
| dioxygen | multiple interactions | ISO | RGD:733118 | 6480464 | SCGB1A1 protein affects the reaction [Oxygen results in increased expression of CXCL2 mRNA] | CTD | PMID:10027076 |
| dioxygen | increases expression | ISO | RGD:733118 | 6480464 | Oxygen results in increased expression of CXCL2 mRNA | CTD | PMID:10027076 |
| divanadium pentaoxide | increases expression | ISO | RGD:733118 | 6480464 | vanadium pentoxide results in increased expression of CXCL2 protein | CTD | PMID:9707512 |
| dobutamine | multiple interactions | ISO | RGD:733118 | 6480464 | Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL2 mRNA] | CTD | PMID:11605937 |
| domperidone | multiple interactions | ISO | RGD:733118 | 6480464 | Domperidone inhibits the reaction [Indomethacin results in increased expression of CXCL2 mRNA] | CTD | PMID:21691039 |
| edaravone | multiple interactions | ISO | RGD:70069 | 6480464 | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CXCL2 mRNA] | CTD | PMID:12954792 |
| edaravone | decreases expression | ISO | RGD:70069 | 6480464 | phenylmethylpyrazolone results in decreased expression of CXCL2 mRNA | CTD | PMID:15948865 |
| elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of CXCL2 mRNA | CTD | PMID:17293063 |
| emodin | multiple interactions | ISO | RGD:70069 | 6480464 | Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA] | CTD | PMID:18590720 |
| enflurane | increases expression | ISO | RGD:70069 | 6480464 | Enflurane results in increased expression of CXCL2 mRNA | CTD | PMID:10422944 |
| ethanol | increases secretion | ISO | RGD:70069 | 6480464 | Ethanol results in increased secretion of CXCL2 protein | CTD | PMID:16385181 |
| ethanol | increases expression | ISO | RGD:70069 | 6480464 | Ethanol results in increased expression of CXCL2 mRNA | CTD | PMID:20116195 |
| ethanol | multiple interactions | ISO | RGD:70069 | 6480464 | allyl sulfide inhibits the reaction [Ethanol results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:20116195 |
| ferroheme b | increases expression | ISO | RGD:733118 | 6480464 | Heme metabolite results in increased expression of CXCL2 mRNA | CTD | PMID:19191707 |
| fomepizole | multiple interactions | ISO | RGD:70069 | 6480464 | fomepizole inhibits the reaction [Ethanol results in increased expression of CXCL2 mRNA] | CTD | PMID:20116195 |
| fulvestrant | multiple interactions | ISO | RGD:733118 | 6480464 | fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]] | CTD | PMID:21501669 |
| fulvestrant | multiple interactions | ISO | RGD:70069 | 6480464 | fulvestrant inhibits the reaction [resveratrol results in decreased expression of CXCL2 protein] | CTD | PMID:21192278 |
| gadolinium trichloride | multiple interactions | ISO | RGD:733118 | 6480464 | gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA] | CTD | PMID:22157104 |
| glucose | increases expression | ISO | RGD:733118 | 6480464 | Glucose results in increased expression of CXCL2 mRNA | CTD | PMID:17178593 |
| gold atom | multiple interactions | ISO | RGD:733118 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL2 mRNA | CTD | PMID:19695318 |
| gold atom | increases secretion | ISO | RGD:733118 | 6480464 | Gold results in increased secretion of CXCL2 protein | CTD | PMID:22155353 |
| gold atom | multiple interactions | ISO | RGD:733118 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein | CTD | PMID:22155353 |
| gold(0) | multiple interactions | ISO | RGD:733118 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL2 mRNA | CTD | PMID:19695318 |
| gold(0) | increases secretion | ISO | RGD:733118 | 6480464 | Gold results in increased secretion of CXCL2 protein | CTD | PMID:22155353 |
| gold(0) | multiple interactions | ISO | RGD:733118 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein | CTD | PMID:22155353 |
| halothane | decreases expression | ISO | RGD:70069 | 6480464 | Halothane results in decreased expression of CXCL2 mRNA | CTD | PMID:15564938 |
| halothane | increases expression | ISO | RGD:733118 | 6480464 | Halothane results in increased expression of CXCL2 mRNA | CTD | PMID:21501669 PMID:22157104 |
| halothane | multiple interactions | ISO | RGD:733118 | 6480464 | gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:22157104 |
| halothane | multiple interactions | ISO | RGD:733118 | 6480464 | Estradiol inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:21501669 |
| halothane | increases expression | ISO | RGD:733118 | 6480464 | Halothane results in increased expression of CXCL2 protein | CTD | PMID:19633216 |
| halothane | increases expression | ISO | RGD:70069 | 6480464 | Halothane results in increased expression of CXCL2 mRNA | CTD | PMID:10422944 |
| heparin | multiple interactions | ISO | RGD:70069 | 6480464 | Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:16401727 |
| hydrogen chloride | increases expression | ISO | RGD:70069 | 6480464 | Hydrochloric Acid results in increased expression of CXCL2 mRNA; more ... | CTD | PMID:16129981 |
| hydrogen chloride | multiple interactions | ISO | RGD:70069 | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:16129981 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of CXCL2 mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | multiple interactions | ISO | RGD:70069 | 6480464 | [Asbestos, Crocidolite results in increased abundance of Hydrogen Peroxide] which results in increased expression of CXCL2 mRNA; more ... | CTD | PMID:11764986 |
| hydrogen peroxide | increases expression | ISO | RGD:733118 | 6480464 | Hydrogen Peroxide results in increased expression of CXCL2 mRNA | CTD | PMID:8480341 |
| ibuprofen | multiple interactions | ISO | RGD:70069 | 6480464 | Ibuprofen inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL2 protein] | CTD | PMID:11545620 |
| indomethacin | multiple interactions | ISO | RGD:733118 | 6480464 | Indomethacin inhibits the reaction [Mustard Gas results in increased expression of CXCL2 mRNA] | CTD | PMID:16377760 |
| indomethacin | increases expression | ISO | RGD:70069 | 6480464 | Indomethacin results in increased expression of CXCL2 mRNA | CTD | PMID:11950807 |
| indomethacin | increases expression | ISO | RGD:733118 | 6480464 | Indomethacin results in increased expression of CXCL2 mRNA | CTD | PMID:21691039 |
| indomethacin | multiple interactions | ISO | RGD:733118 | 6480464 | Domperidone inhibits the reaction [Indomethacin results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:21691039 |
| iron atom | multiple interactions | ISO | RGD:70069 | 6480464 | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of CXCL2 protein | CTD | PMID:22198552 |
| iron trichloride | multiple interactions | ISO | RGD:70069 | 6480464 | ferric chloride inhibits the reaction [Asbestos, Amphibole results in increased expression of CXCL2] | CTD | PMID:21605006 |
| isoflurane | decreases expression | ISO | RGD:70069 | 6480464 | Isoflurane results in decreased expression of CXCL2 mRNA | CTD | PMID:15564938 |
| isoflurane | increases expression | ISO | RGD:70069 | 6480464 | Isoflurane results in increased expression of CXCL2 mRNA | CTD | PMID:10422944 |
| L-methionine | multiple interactions | ISO | RGD:733118 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with RXRA gene mutant form] results in increased expression of CXCL2 mRNA | CTD | PMID:18952117 |
| L-methionine | multiple interactions | ISO | RGD:733118 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of CXCL2 mRNA | CTD | PMID:20697377 |
| manganese atom | increases expression | EXP | | 6480464 | Manganese results in increased expression of CXCL2 mRNA | CTD | PMID:17175027 |
| manganese atom | increases expression | ISO | RGD:70069 | 6480464 | Manganese results in increased expression of CXCL2 mRNA | CTD | PMID:19782702 PMID:20224926 |
| manganese(0) | increases expression | EXP | | 6480464 | Manganese results in increased expression of CXCL2 mRNA | CTD | PMID:17175027 |
| manganese(0) | increases expression | ISO | RGD:70069 | 6480464 | Manganese results in increased expression of CXCL2 mRNA | CTD | PMID:19782702 PMID:20224926 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of CXCL2 mRNA | CTD | PMID:17175027 |
| mercaptopurine | increases expression | ISO | RGD:70069 | 6480464 | 6-Mercaptopurine results in increased expression of CXCL2 mRNA | CTD | PMID:23358152 |
| metoclopramide | multiple interactions | ISO | RGD:733118 | 6480464 | Metoclopramide inhibits the reaction [Indomethacin results in increased expression of CXCL2 mRNA] | CTD | PMID:21691039 |
| mifepristone | multiple interactions | ISO | RGD:733118 | 6480464 | Mifepristone inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA] | CTD | PMID:22157104 |
| mifepristone | multiple interactions | ISO | RGD:733118 | 6480464 | Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]] | CTD | PMID:21501669 |
| mycophenolic acid | increases expression | ISO | RGD:733118 | 6480464 | Mycophenolic Acid results in increased expression of CXCL2 protein | CTD | PMID:19818335 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of CXCL2 mRNA] | CTD | PMID:19350554 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:733118 | 6480464 | Acetylcysteine inhibits the reaction [Paraquat results in increased expression of CXCL2 protein] | CTD | PMID:16919916 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:733118 | 6480464 | Acetylcysteine inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased secretion of CXCL2 protein] | CTD | PMID:21507677 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Vanadates results in increased expression of CXCL2 mRNA] | CTD | PMID:10718115 |
| naphthalene | increases expression | ISO | RGD:733118 | 6480464 | naphthalene results in increased expression of CXCL2 mRNA | CTD | PMID:18978301 |
| naproxen | multiple interactions | ISO | RGD:70069 | 6480464 | Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]; more ... | CTD | PMID:22150557 |
| nickel atom | multiple interactions | ISO | RGD:70069 | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CXCL2 protein; more ... | CTD | PMID:22198552 |
| nickel atom | increases expression | ISO | RGD:733118 | 6480464 | Nickel results in increased expression of CXCL2 protein | CTD | PMID:11919079 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of CXCL2 mRNA | CTD | PMID:17312168 |
| nickel sulfate | increases expression | ISO | RGD:70069 | 6480464 | nickel sulfate results in increased expression of CXCL2 mRNA | CTD | PMID:11708899 |
| nickel sulfate | affects expression | EXP | | 6480464 | nickel sulfate affects the expression of CXCL2 mRNA | CTD | PMID:18202158 |
| nitrogen dioxide | increases expression | ISO | RGD:733118 | 6480464 | Nitrogen Dioxide results in increased expression of CXCL2 mRNA | CTD | PMID:10715624 |
| nitrogen dioxide | multiple interactions | ISO | RGD:70069 | 6480464 | [Ozone co-treated with Nitrogen Dioxide] results in increased expression of CXCL2 mRNA | CTD | PMID:10986008 |
| nitrogen dioxide | increases expression | ISO | RGD:733118 | 6480464 | Nitrogen Dioxide results in increased expression of CXCL2 protein | CTD | PMID:11498801 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | CPE gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein] | CTD | PMID:16002559 |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 protein | CTD | PMID:11498801 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:10027076 more ... |
| ozone | increases expression | ISO | RGD:70069 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:10706030 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 protein | CTD | PMID:18007984 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:19555225 more ... |
| ozone | increases expression | ISO | RGD:70069 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:9439717 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 protein | CTD | PMID:17307210 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:19555225 more ... |
| ozone | increases expression | ISO | RGD:70069 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:9439717 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 protein | CTD | PMID:16002559 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:17307210 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 protein | CTD | PMID:15516495 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:10715624 more ... |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | IL10 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 mRNA] | CTD | PMID:20826374 |
| ozone | increases expression | ISO | RGD:70069 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:16330353 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 protein | CTD | PMID:17575079 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:17460151 more ... |
| ozone | increases expression | ISO | RGD:70069 | 6480464 | Ozone results in increased expression of CXCL2 protein | CTD | PMID:10706030 |
| ozone | multiple interactions | ISO | RGD:70069 | 6480464 | [Ozone co-treated with Nitrogen Dioxide] results in increased expression of CXCL2 mRNA | CTD | PMID:10986008 |
| ozone | increases expression | ISO | RGD:70069 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:9439717 more ... |
| ozone | multiple interactions | ISO | RGD:70069 | 6480464 | IL1B protein affects the reaction [Ozone results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:9439717 |
| ozone | multiple interactions | ISO | RGD:70069 | 6480464 | Dexamethasone inhibits the reaction [Ozone results in increased expression of CXCL2 mRNA] | CTD | PMID:7737418 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | SFTPA1 gene mutant form inhibits the reaction [Ozone results in increased expression of CXCL2 mRNA] | CTD | PMID:17307210 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | SCGB1A1 protein affects the reaction [Ozone results in increased expression of CXCL2 mRNA] | CTD | PMID:10027076 |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 protein | CTD | PMID:11498801 more ... |
| ozone | increases expression | ISO | RGD:733118 | 6480464 | Ozone results in increased expression of CXCL2 mRNA | CTD | PMID:10715624 more ... |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | LEPR gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein] | CTD | PMID:16373670 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:18007984 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | IL1R1 gene mutant form affects the reaction [Ozone results in increased expression of CXCL2 protein] | CTD | PMID:17575079 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | Endotoxins promotes the reaction [Ozone results in increased expression of CXCL2 mRNA] | CTD | PMID:12217210 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | ERCC6 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein] | CTD | PMID:17095637 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | Dexamethasone inhibits the reaction [Ozone results in increased expression of CXCL2 protein]; more ... | CTD | PMID:14754758 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | CR1L protein affects the reaction [Ozone results in increased expression of CXCL2 protein] | CTD | PMID:14701711 |
| ozone | multiple interactions | ISO | RGD:733118 | 6480464 | [Acetaminophen co-treated with Ozone] results in increased expression of CXCL2 mRNA | CTD | PMID:20123758 |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:10774834 more ... |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:10774834 more ... |
| paracetamol | multiple interactions | ISO | RGD:733118 | 6480464 | MST1R protein affects the reaction [Acetaminophen results in increased expression of CXCL2 mRNA] | CTD | PMID:22575169 |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:10774834 more ... |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CXCL2 mRNA | CTD | PMID:21420995 |
| paracetamol | multiple interactions | ISO | RGD:733118 | 6480464 | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of CXCL2 mRNA] | CTD | PMID:22461450 |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:10774834 more ... |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:20123758 more ... |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 protein | CTD | PMID:10774834 more ... |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 protein | CTD | PMID:10774834 more ... |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:16781746 more ... |
| paracetamol | multiple interactions | ISO | RGD:733118 | 6480464 | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CXCL2 mRNA] | CTD | PMID:12153990 |
| paracetamol | multiple interactions | ISO | RGD:733118 | 6480464 | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:14557383 |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 protein | CTD | PMID:17439248 more ... |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:14557383 more ... |
| paracetamol | multiple interactions | ISO | RGD:733118 | 6480464 | [Acetaminophen co-treated with Ozone] results in increased expression of CXCL2 mRNA | CTD | PMID:20123758 |
| paracetamol | affects expression | ISO | RGD:733118 | 6480464 | Acetaminophen affects the expression of CXCL2 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:20123758 more ... |
| paracetamol | increases expression | ISO | RGD:733118 | 6480464 | Acetaminophen results in increased expression of CXCL2 mRNA | CTD | PMID:20123758 more ... |
| paraquat | multiple interactions | ISO | RGD:733118 | 6480464 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Paraquat results in increased expression of CXCL2 protein]; more ... | CTD | PMID:16919916 |
| paraquat | increases expression | ISO | RGD:70069 | 6480464 | Paraquat results in increased expression of CXCL2 protein | CTD | PMID:12504350 |
| paraquat | increases expression | ISO | RGD:733118 | 6480464 | Paraquat results in increased expression of CXCL2 protein | CTD | PMID:16919916 |
| paraquat | increases expression | ISO | RGD:733118 | 6480464 | Paraquat results in increased expression of CXCL2 mRNA | CTD | PMID:16324872 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:733118 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CXCL2 mRNA | CTD | PMID:20852150 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:733118 | 6480464 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCL2 mRNA] | CTD | PMID:20852150 |
| pirinixic acid | multiple interactions | ISO | RGD:733118 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL2 protein] | CTD | PMID:18653653 |
| pirinixic acid | multiple interactions | ISO | RGD:733118 | 6480464 | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CXCL2 mRNA] | CTD | PMID:15814532 |
| piroxicam | increases expression | EXP | | 6480464 | Piroxicam results in increased expression of CXCL2 mRNA | CTD | PMID:21858171 |
| progesterone | multiple interactions | ISO | RGD:733118 | 6480464 | gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:22157104 |
| progesterone | multiple interactions | ISO | RGD:733118 | 6480464 | Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]] | CTD | PMID:21501669 |
| prostaglandin D2 | multiple interactions | ISO | RGD:733118 | 6480464 | [Lipopolysaccharides results in increased abundance of Prostaglandin D2] which results in increased expression of CXCL2 protein; more ... | CTD | PMID:21166666 |
| prostaglandin D2 | increases expression | ISO | RGD:733118 | 6480464 | Prostaglandin D2 results in increased expression of CXCL2 protein | CTD | PMID:21166666 |
| prostaglandin E1 | multiple interactions | ISO | RGD:733118 | 6480464 | Alprostadil inhibits the reaction [Carbamazepine results in increased expression of CXCL2 mRNA] | CTD | PMID:22790970 |
| purine-6-thiol | increases expression | ISO | RGD:70069 | 6480464 | 6-Mercaptopurine results in increased expression of CXCL2 mRNA | CTD | PMID:23358152 |
| quartz | multiple interactions | ISO | RGD:70069 | 6480464 | [Quartz results in increased abundance of Hydrogen Peroxide] which results in increased expression of CXCL2 mRNA; more ... | CTD | PMID:11764986 |
| quartz | increases expression | ISO | RGD:70069 | 6480464 | Quartz results in increased expression of CXCL2 mRNA | CTD | PMID:11764986 |
| quercetin | multiple interactions | ISO | RGD:733118 | 6480464 | Quercetin inhibits the reaction [TNF protein promotes the reaction [CREBBP protein binds to CXCL2 promoter]]; more ... | CTD | PMID:17449583 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CXCL2 mRNA | CTD | PMID:21632981 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | ISO | RGD:70069 | 6480464 | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CXCL2 protein] | CTD | PMID:14654164 |
| ranitidine | multiple interactions | ISO | RGD:70069 | 6480464 | Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:16401727 |
| ranitidine | multiple interactions | ISO | RGD:70069 | 6480464 | Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of CXCL2 mRNA] | CTD | PMID:16415329 |
| ranitidine | multiple interactions | ISO | RGD:70069 | 6480464 | Pentoxifylline inhibits the reaction [[Ranitidine co-treated with Lipopolysaccharides] results in increased expression of CXCL2 protein] | CTD | PMID:17698507 |
| resveratrol | multiple interactions | ISO | RGD:70069 | 6480464 | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CXCL2 mRNA] | CTD | PMID:15734790 |
| resveratrol | decreases expression | ISO | RGD:70069 | 6480464 | resveratrol results in decreased expression of CXCL2 mRNA | CTD | PMID:19228061 |
| resveratrol | multiple interactions | ISO | RGD:70069 | 6480464 | fulvestrant inhibits the reaction [resveratrol results in decreased expression of CXCL2 protein]; more ... | CTD | PMID:21192278 |
| resveratrol | decreases expression | ISO | RGD:70069 | 6480464 | resveratrol results in decreased expression of CXCL2 protein | CTD | PMID:21192278 |
| rosiglitazone | decreases expression | ISO | RGD:70069 | 6480464 | rosiglitazone results in decreased expression of CXCL2 mRNA | CTD | PMID:21515302 |
| rotenone | multiple interactions | ISO | RGD:70069 | 6480464 | Rotenone inhibits the reaction [Quartz results in increased expression of CXCL2 mRNA] | CTD | PMID:11764986 |
| selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of CXCL2 mRNA | CTD | PMID:17293063 |
| sevoflurane | decreases expression | ISO | RGD:70069 | 6480464 | sevoflurane results in decreased expression of CXCL2 mRNA | CTD | PMID:15564938 |
| sevoflurane | increases expression | ISO | RGD:70069 | 6480464 | sevoflurane results in increased expression of CXCL2 mRNA | CTD | PMID:10422944 |
| silicon dioxide | increases expression | ISO | RGD:70069 | 6480464 | Silicon Dioxide results in increased expression of CXCL2 protein | CTD | PMID:21602193 |
| silicon dioxide | multiple interactions | ISO | RGD:733118 | 6480464 | IL17A protein affects the reaction [Silicon Dioxide results in increased expression of CXCL2 protein]; more ... | CTD | PMID:20421647 |
| silicon dioxide | increases expression | ISO | RGD:733118 | 6480464 | Silicon Dioxide results in increased expression of CXCL2 protein | CTD | PMID:20421647 |
| silicon dioxide | multiple interactions | ISO | RGD:733118 | 6480464 | Silicon Dioxide promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein] | CTD | PMID:22815821 |
| silicon dioxide | multiple interactions | ISO | RGD:733118 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein | CTD | PMID:22155353 |
| silicon dioxide | increases expression | ISO | RGD:733118 | 6480464 | Silicon Dioxide results in increased expression of CXCL2 mRNA | CTD | PMID:19073995 |
| silver atom | increases expression | ISO | RGD:70069 | 6480464 | Silver analog results in increased expression of CXCL2 mRNA | CTD | PMID:23086748 |
| silver(0) | increases expression | ISO | RGD:70069 | 6480464 | Silver analog results in increased expression of CXCL2 mRNA | CTD | PMID:23086748 |
| simvastatin | decreases expression | ISO | RGD:733118 | 6480464 | Simvastatin results in decreased expression of CXCL2 protein | CTD | PMID:21330348 |
| simvastatin | decreases expression | ISO | RGD:733118 | 6480464 | Simvastatin results in decreased expression of CXCL2 protein | CTD | PMID:21441352 PMID:21330348 |
| simvastatin | decreases expression | ISO | RGD:733118 | 6480464 | Simvastatin results in decreased expression of CXCL2 protein | CTD | PMID:21330348 PMID:21441352 |
| simvastatin | decreases expression | ISO | RGD:733118 | 6480464 | Simvastatin results in decreased expression of CXCL2 mRNA | CTD | PMID:21441352 |
| sterigmatocystin | increases expression | ISO | RGD:733118 | 6480464 | Sterigmatocystin results in increased expression of CXCL2 mRNA | CTD | PMID:21356202 |
| succimer | multiple interactions | ISO | RGD:733118 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL2 mRNA | CTD | PMID:21641980 |
| sumatriptan | multiple interactions | ISO | RGD:70069 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL2 protein]; more ... | CTD | PMID:22150557 |
| taurocholic acid | multiple interactions | ISO | RGD:733118 | 6480464 | EGR1 protein promotes the reaction [Taurocholic Acid results in increased expression of CXCL2 mRNA]; more ... | CTD | PMID:21224055 |
| taurocholic acid | increases expression | ISO | RGD:733118 | 6480464 | Taurocholic Acid results in increased expression of CXCL2 protein; more ... | CTD | PMID:21224055 |
| temozolomide | decreases secretion | EXP | | 6480464 | temozolomide results in decreased secretion of CXCL2 protein | CTD | PMID:21509778 |
| temozolomide | affects response to substance | EXP | | 6480464 | CXCL2 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of CXCL2 mRNA | CTD | PMID:15336504 |
| tetrachloromethane | decreases expression | ISO | RGD:733118 | 6480464 | Carbon Tetrachloride results in decreased expression of CXCL2 mRNA | CTD | PMID:17484886 |
| tetrachloromethane | increases expression | ISO | RGD:733118 | 6480464 | Carbon Tetrachloride results in increased expression of CXCL2 mRNA | CTD | PMID:17125873 |
| tetradecane | increases expression | ISO | RGD:70069 | 6480464 | n-tetradecane results in increased expression of CXCL2 protein | CTD | PMID:17337753 |
| thapsigargin | multiple interactions | EXP | | 6480464 | 4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of CXCL2 mRNA]; more ... | CTD | PMID:19442820 |
| thioacetamide | multiple interactions | ISO | RGD:733118 | 6480464 | Progesterone promotes the reaction [Thioacetamide results in increased expression of CXCL2 mRNA] | CTD | PMID:22157104 |
| thioacetamide | increases expression | ISO | RGD:733118 | 6480464 | Thioacetamide results in increased expression of CXCL2 mRNA | CTD | PMID:22157104 |
| titanium dioxide | increases expression | ISO | RGD:733118 | 6480464 | titanium dioxide results in increased expression of CXCL2 protein | CTD | PMID:19464567 |
| toluene 2,4-diisocyanate | multiple interactions | ISO | RGD:733118 | 6480464 | AWD 12-281 inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein]; more ... | CTD | PMID:12956900 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:733118 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein | CTD | PMID:12956900 more ... |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:733118 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein | CTD | PMID:12956900 more ... |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:733118 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein | CTD | PMID:17980417 more ... |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:733118 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein | CTD | PMID:17014439 more ... |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:733118 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein | CTD | PMID:16963530 more ... |
| toluene 2,4-diisocyanate | multiple interactions | ISO | RGD:733118 | 6480464 | ICAM1 protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein] | CTD | PMID:17014439 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:733118 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CXCL2 protein | CTD | PMID:17014439 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:70069 | 6480464 | resveratrol affects the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of CXCL2 mRNA] | CTD | PMID:15734790 |
| trans-resveratrol | decreases expression | ISO | RGD:70069 | 6480464 | resveratrol results in decreased expression of CXCL2 mRNA | CTD | PMID:19228061 |
| trans-resveratrol | multiple interactions | ISO | RGD:70069 | 6480464 | fulvestrant inhibits the reaction [resveratrol results in decreased expression of CXCL2 protein]; more ... | CTD | PMID:21192278 |
| trans-resveratrol | decreases expression | ISO | RGD:70069 | 6480464 | resveratrol results in decreased expression of CXCL2 protein | CTD | PMID:21192278 |
| trimellitic anhydride | increases expression | ISO | RGD:733118 | 6480464 | trimellitic anhydride results in increased expression of CXCL2 protein | CTD | PMID:16675337 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CXCL2 mRNA | CTD | PMID:19631733 PMID:19140230 |
| troglitazone | decreases expression | ISO | RGD:70069 | 6480464 | troglitazone results in decreased expression of CXCL2 mRNA | CTD | PMID:21515302 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CXCL2 mRNA | CTD | PMID:19140230 PMID:19631733 |
| troglitazone | decreases expression | ISO | RGD:733118 | 6480464 | troglitazone results in decreased expression of CXCL2 mRNA | CTD | PMID:12468449 |
| tungsten atom | multiple interactions | ISO | RGD:70069 | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CXCL2 protein; more ... | CTD | PMID:22198552 |
| UDP | multiple interactions | ISO | RGD:733118 | 6480464 | P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]] | CTD | PMID:18523137 |
| undecane | increases expression | ISO | RGD:70069 | 6480464 | undecane results in increased expression of CXCL2 protein | CTD | PMID:17337753 |
| ursodeoxycholic acid | decreases expression | ISO | RGD:733118 | 6480464 | Ursodeoxycholic Acid results in decreased expression of CXCL2 protein; more ... | CTD | PMID:17888421 |
| ursodeoxycholic acid | decreases secretion | ISO | RGD:733118 | 6480464 | Ursodeoxycholic Acid results in decreased secretion of CXCL2 protein | CTD | PMID:17888421 |
| vanadium atom | increases expression | ISO | RGD:70069 | 6480464 | Vanadium results in increased expression of CXCL2 mRNA | CTD | PMID:11708899 |
| vanadium(0) | increases expression | ISO | RGD:70069 | 6480464 | Vanadium results in increased expression of CXCL2 mRNA | CTD | PMID:11708899 |
| vanadyl sulfate | increases expression | EXP | | 6480464 | vanadyl sulfate results in increased expression of CXCL2 protein | CTD | PMID:18684396 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; more ... | CTD | PMID:15608143 |
| zinc atom | increases expression | ISO | RGD:70069 | 6480464 | Zinc deficiency results in increased expression of CXCL2 mRNA | CTD | PMID:22689922 |
| zinc sulfate | increases expression | ISO | RGD:70069 | 6480464 | Zinc Sulfate results in increased expression of CXCL2 mRNA | CTD | PMID:11708899 |
| zinc sulfate | decreases expression | EXP | | 6480464 | Zinc Sulfate results in decreased expression of CXCL2 mRNA | CTD | PMID:19013360 |
| zinc(0) | increases expression | ISO | RGD:70069 | 6480464 | Zinc deficiency results in increased expression of CXCL2 mRNA | CTD | PMID:22689922 |